The Israeli research institute Miguel has developed a vaccine for the Corona virus in poultry - which is genetically identical to human
The research conducted at the Miguel Research Institute by the researchers: Prof. Jacob Pitkowski, Dr. Chen Katz, Dr. Ehud Shahar and their team - indicates that the virus in the birds has a high genetic identity to the human COVID-19 virus. The study also found that the mechanism of infection of both viruses is the same, an important scientific fact that increases the chance of getting vaccinated in humans in a very short time.
The efficacy of the new poultry vaccine has been successfully demonstrated in preclinical trials conducted at the Volcanic Institute. After adjusting the genetic continuum for human coronary disease, COVID-19, Miguel awaits product safety approval to begin producing vaccines against the world's most prevalent disease, of which 2,666 patients have died so far.
Dr. Ehud Shachar added: "Poultry corona has more solutions in the market, but these are not solutions that can be translated into human corona and ours, because it is a genetic material that makes a protein from it, and that can be translated from a poultry sequence to a virus-compatible sequence. That attacks humans. "
However, it will take many more months for the new vaccine to be approved for human use. David Zigdon, CEO of the Miguel Research Institute, explains: "We will work to accelerate development processes to reach an effective COVID-19 vaccine over the next 8-10 weeks, and we will reach a safety trial in 90 days." Reach the market in at least six months
